Tiernan O’mAlley

Tiernan O’mAlley

Auto-generated profile, based on publicly available information

Tiernan O’mAlley

Biogen, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
SLSara Linse
Sara Linse
TSTom Scheidt
Tom Scheidt
KBKatja Bernfur
Katja Bernfur
Michele VendruscoloMichele Vendruscolo
Michele Vendruscolo
CDChristopher M. Dobson
Christopher M. Dobson
OHOskar Hansson
Oskar Hansson

4 September 2015 in Science Advances
Verified
Journal Article
Open access
PDF file
JKJames Keaney
James Keaney
DWDominic M. Walsh
Dominic M. Walsh
TOTiernan O’malley
Tiernan O’malley
NHNatalie Hudson
Natalie Hudson
DCDarragh E. Crosbie
Darragh E. Crosbie
MCMatthew Campbell
Matthew Campbell
Size-selective and passive paracellular diffusion of amyloid-β across tight junctions of the blood-brain barrier in Alzheimer’s disease.

29 July 2015 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DKDaniel Kanmert
Daniel Kanmert
ACAdam Cantlon
Adam Cantlon
CMChristina R. Muratore
Christina R. Muratore
MJMing Jin
Ming Jin
TOTiernan T. O'Malley
Tiernan T. O'Malley
DWDominic M. Walsh
Dominic M. Walsh
Recent evidence suggests that tau aggregation may spread via extracellular release and subsequent uptake by synaptically connected neurons, but little is known about the processes by which tau is released or the molecular forms of extracellular tau. To gain insight into the nature of extracellular tau, we used highly sensitive ELISAs, which, when used in tandem, are capable of differentiating between full-length (FL) tau, mid-region-bearing fragments, and C-terminal (CT) fragments. We applied these assays to the systematic study of the conditioned media of N2a cells, induced pluripotent stem cell-derived human cortical neurons, and primary rat cortical neurons, each of which was carefully assessed for viability. In all three neuronal models, the bulk of extracellular tau was free-floating and unaggregated and <0.2% was encapsulated in exosomes. Although most intracellular tau was FL, the majority of extracellular tau was CT truncated and appeared to be released both actively by living neurons and passively by dead cells. In contrast, only a small amount of extracellular tau was aggregation-competent tau (i.e., contained the microtubule-binding regions) and this material appears to be released solely due to a low level of cell death that occurs in all cell culture systems. Importantly, amyloid β-protein (Aβ)-induced neuronal compromise significantly increased the quantity of all forms of extracellular tau, but the presence of Aβ before detectable cell compromise did not increase extracellular tau. Collectively, these results suggest that factors that induce neuronal death are likely to be necessary to initiate the extracellular spread of tau aggregation.